Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: Endorsed by the American College of Cardiology

JACC Clin Electrophysiol. 2020 Aug;6(8):1053-1066. doi: 10.1016/j.jacep.2020.06.004. Epub 2020 Jun 12.

Abstract

Coronavirus disease 2019 (COVID-19) has presented substantial challenges to patient care and impacted health care delivery, including cardiac electrophysiology practice throughout the globe. Based upon the undetermined course and regional variability of the pandemic, there is uncertainty as to how and when to resume and deliver electrophysiology services for arrhythmia patients. This joint document from representatives of the Heart Rhythm Society, American Heart Association, and American College of Cardiology seeks to provide guidance for clinicians and institutions reestablishing safe electrophysiological care. To achieve this aim, we address regional and local COVID-19 disease status, the role of viral screening and serologic testing, return-to-work considerations for exposed or infected health care workers, risk stratification and management strategies based on COVID-19 disease burden, institutional preparedness for resumption of elective procedures, patient preparation and communication, prioritization of procedures, and development of outpatient and periprocedural care pathways.

Keywords: COVID-19; arrhythmia management; cardiac electrophysiology.

Publication types

  • Practice Guideline

MeSH terms

  • Ambulatory Care
  • American Heart Association
  • Arrhythmias, Cardiac / diagnosis*
  • Arrhythmias, Cardiac / therapy*
  • Betacoronavirus
  • COVID-19
  • COVID-19 Testing
  • Cardiology*
  • Clinical Laboratory Techniques
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / prevention & control
  • Decision Making, Shared
  • Delivery of Health Care*
  • Electrophysiologic Techniques, Cardiac*
  • Health Personnel
  • Humans
  • Mass Screening
  • Organizational Policy
  • Pandemics / prevention & control
  • Patient Selection
  • Personal Protective Equipment / supply & distribution
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / prevention & control
  • Return to Work
  • Risk Assessment
  • SARS-CoV-2
  • Telemedicine
  • United States / epidemiology